The impact of DNA methylation in hematopoietic malignancies
Aberrant DNA methylation is a characteristic feature of cancers including blood
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
The Impact of DNA Methylation in Hematopoietic Malignancies
M Guillamot, L Cimmino, I Aifantis - Trends in Cancer, 2016 - scholarship.miami.edu
Aberrant DNA methylation is a characteristic feature of cancers including blood
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
The Impact of DNA Methylation in Hematopoietic Malignancies
M Guillamot, L Cimmino, I Aifantis - Trends in Cancer, 2016 - cell.com
Aberrant DNA methylation is a characteristic feature of cancers including blood
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
[引用][C] The Impact of DNA Methylation in Hematopoietic Malignancies
M Guillamot, L Cimmino, I Aifantis - Trends in Cancer, 2016 - cir.nii.ac.jp
The Impact of DNA Methylation in Hematopoietic Malignancies | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
The Impact of DNA Methylation in Hematopoietic Malignancies
M Guillamot, L Cimmino, I Aifantis - Trends in Cancer, 2016 - Elsevier
Aberrant DNA methylation is a characteristic feature of cancers including blood
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
The Impact of DNA Methylation in Hematopoietic Malignancies.
M Guillamot, L Cimmino, I Aifantis - Trends in Cancer, 2016 - europepmc.org
Aberrant DNA methylation is a characteristic feature of cancer including blood malignancies.
Mutations in the DNA methylation regulators DNMT3A, TET1/2 and IDH1/2 are recurrent in …
Mutations in the DNA methylation regulators DNMT3A, TET1/2 and IDH1/2 are recurrent in …
[HTML][HTML] The Impact of DNA Methylation in Hematopoietic Malignancies
M Guillamot, L Cimmino, I Aifantis - Trends in cancer, 2016 - ncbi.nlm.nih.gov
Aberrant DNA methylation is a characteristic feature of cancer including blood malignancies.
Mutations in the DNA methylation regulators DNMT3A, TET1/2 and IDH1/2 are recurrent in …
Mutations in the DNA methylation regulators DNMT3A, TET1/2 and IDH1/2 are recurrent in …
The Impact of DNA Methylation in Hematopoietic Malignancies
M Guillamot, L Cimmino, I Aifantis - Trends in Cancer, 2016 - infona.pl
Aberrant DNA methylation is a characteristic feature of cancers including blood
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
malignancies. Mutations in the DNA methylation regulators DNMT3A, TET1/2, and IDH1/2 …
The Impact of DNA Methylation in Hematopoietic Malignancies
M Guillamot, L Cimmino, I Aifantis - Trends in cancer, 2016 - pubmed.ncbi.nlm.nih.gov
Aberrant DNA methylation is a characteristic feature of cancer including blood malignancies.
Mutations in the DNA methylation regulators DNMT3A, TET1/2 and IDH1/2 are recurrent in …
Mutations in the DNA methylation regulators DNMT3A, TET1/2 and IDH1/2 are recurrent in …
The Impact of DNA Methylation in Hematopoietic Malignancies.
M Guillamot, L Cimmino, I Aifantis - Trends in Cancer, 2016 - europepmc.org
Aberrant DNA methylation is a characteristic feature of cancer including blood malignancies.
Mutations in the DNA methylation regulators DNMT3A, TET1/2 and IDH1/2 are recurrent in …
Mutations in the DNA methylation regulators DNMT3A, TET1/2 and IDH1/2 are recurrent in …